Correlating the melting point alteration with the supramolecular structure in aripiprazole drug cocrystals

Non-Covalent Derivatives: Cocrystals and Eutectics

(2015) Emily Stoler et al.   MOLECULES

Low-Temperature Phase Transition in Crystalline Aripiprazole Leads to an Eighth Polymorph

(2014) Sean P. Delaney et al.   CRYSTAL GROWTH & DESIGN

Pharmaceutical co-crystals – are we there yet?

(2014) N. Blagden et al.   CRYSTENGCOMM

Aripiprazole salts IV. Anionic plus solvato networks defining molecular conformation

(2014) Eleonora Freire et al.   JOURNAL OF MOLECULAR STRUCTURE

Aripiprazole salts. III. Bis(aripiprazolium) oxalate–oxalic acid (1/1)

(2013) Eleonora Freire et al.   ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS

Evaluating the Roles of Conformational Strain and Cohesive Binding in Crystalline Polymorphs of Aripiprazole

(2013) Sean P. Delaney et al.   CRYSTAL GROWTH & DESIGN

Adaptability of aripiprazole towards forming isostructural hydrogen bonding networks in multi-component salts: a rare case of strong O–H⋯O− ↔ weak C–H⋯O mimicry

(2013) Jagadeesh Babu Nanubolu et al.   CRYSTENGCOMM

The role of co-crystals in pharmaceutical design

(2013) Jonathan W. Steed   TRENDS IN PHARMACOLOGICAL SCIENCES

Aripiprazole salts. I. Aripiprazole nitrate

(2012) Eleonora Freire et al.   ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS

Aripiprazole salts. II. Aripiprazole perchlorate

(2012) Eleonora Freire et al.   ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS

Crystal Engineering of Stable Temozolomide Cocrystals

(2012) N. Jagadeesh Babu et al.   Chemistry-An Asian Journal

Polymorphs, Salts, and Cocrystals: What’s in a Name?

(2012) Srinivasulu Aitipamula et al.   CRYSTAL GROWTH & DESIGN

Sixth polymorph of aripiprazole - an antipsychotic drug

(2012) Jagadeesh Babu Nanubolu et al.   CRYSTENGCOMM

Acid–base crystalline complexes and the pKa rule

(2012) Aurora J. Cruz-Cabeza   CRYSTENGCOMM

Pharmaceutical cocrystals and poorly soluble drugs

(2012) Ranjit Thakuria et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Pharmaceutical Cocrystals: The Coming Wave of New Drug Substances

(2012) Harry G. Brittain   JOURNAL OF PHARMACEUTICAL SCIENCES

Solubility Advantage of Amorphous Drugs and Pharmaceutical Cocrystals

(2011) N. Jagadeesh Babu et al.   CRYSTAL GROWTH & DESIGN

Packing incentives and a reliable N–H⋯N–pyridine synthon in co-crystallization of bipyridines with two agrochemical actives

(2011) Elisa Nauha et al.   CRYSTENGCOMM

The crystal structures and melting point properties of isonicotinamide cocrystals with alkanediacids HO2C(CH2)n−2CO2H n = 7–9

(2011) Laura J. Thompson et al.   CRYSTENGCOMM

Understanding the relationship between crystal structure, plasticity and compaction behaviour of theophylline, methyl gallate, and their 1 : 1 co-crystal

(2010) Sayantan Chattoraj et al.   CRYSTENGCOMM

Remarkable reversal of melting point alternation by co-crystallization

(2010) Dario Braga et al.   CRYSTENGCOMM

Solubility Advantage of Pharmaceutical Cocrystals

(2009) David J. Good et al.   CRYSTAL GROWTH & DESIGN

Pharmaceutical Cocrystals and Their Physicochemical Properties

(2009) Nate Schultheiss et al.   CRYSTAL GROWTH & DESIGN

Using Cocrystals To Systematically Modulate Aqueous Solubility and Melting Behavior of an Anticancer Drug

(2009) Christer B. Aakeröy et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Halogen bonds as orthogonal molecular interactions to hydrogen bonds

(2009) Andrea Regier Voth et al.   Nature Chemistry

Hirshfeld surface analysis

(2008) Mark A. Spackman et al.   CRYSTENGCOMM

Mercury CSD 2.0– new features for the visualization and investigation of crystal structures

(2008) Clare F. Macrae et al.   JOURNAL OF APPLIED CRYSTALLOGRAPHY

Conformational polymorphism in aripiprazole: Preparation, stability and structure of five modifications

(2008) Doris E. Braun et al.   JOURNAL OF PHARMACEUTICAL SCIENCES